Pharma Journalist -

Takeda, Zedira and Dr. Falk Pharma GmbH announced a collaboration and licensing agreement to develop ZED1227/TAK-227, a Phase 2b investigational therapy for the treatment of celiac…
Read More...

Amgen announced that it has successfully completed its previously announced acquisition of ChemoCentryx, Inc., a biopharmaceutical company focused on orally administered therapeutics to…
Read More...

AbbVie announced the acquisition of DJS Antibodies Ltd ("DJS"), a privately-held UK-based biotechnology company dedicated to discovering and developing antibody medicines that target…
Read More...

Novavax, Inc. announced that the Novavax COVID-19 Vaccine, Adjuvanted (NVX-CoV2373) has received emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) to…
Read More...

Catalent, the global leader in enabling biopharma, cell, gene and consumer health partners to optimize development, launch, and supply of better patient treatments across multiple…
Read More...

Zymeworks Inc. announced that management will host a conference call and webcast to discuss Zymeworks has entered into an exclusive licensing agreement for zanidatamab, a HER2-targeted…
Read More...

Telesis Bio and Cellibre announced initiation of work under a collaboration to optimize the development and validation of Telesis Bio’s BioXp Digital-to-Biological Converter (DBC)…
Read More...

Ginkgo Bioworks and Zymergen announced that Ginkgo has completed its previously announced acquisition of Zymergen. The acquisition is expected to significantly enhance Ginkgo's platform…
Read More...

PIC Therapeutics, Inc., a biopharmaceutical company dedicated to developing life-changing medicines for patients with cancer, announced the closing of a $35 million Series A financing…
Read More...

Ayala Pharmaceuticals, Inc. (Ayala), a clinical-stage oncology company focused on developing and commercializing small molecule therapeutics for patients suffering from rare tumors and…
Read More...